CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response.
Cell Metab. 2018 Jan 9;27(1):85-100.e8. doi: 10.1016/j.cmet.2017.10.006. Epub 2017 Nov 9.
Cell Metab. 2018.
PMID: 29129787
Free PMC article.